•
Dec 31, 2022

Immuneering Q4 2022 Earnings Report

Total Revenue
$456
Previous year: $190K
-99.8%
EPS
-$0.5
Previous year: -$0.42
+19.0%
Gross Profit
-$158M
Previous year: -$16.6K
+949770.2%
Cash and Equivalents
$72.6M
Previous year: $74.9M
-3.0%
Free Cash Flow
-$11.8M
Previous year: -$9.25M
+27.7%
Total Assets
$122M
Previous year: $167M
-26.6%

Immuneering

Immuneering